CONNECT WITH US
Gaming

Gaming

Remedy reports revenue declines in Q2 and H1 as it prepares for Control Resonant launch

GamesIndustry.biz logo

Published on

Add as a preferred source on Google
Remedy reports revenue declines in Q2 and H1 as it prepares for Control Resonant launch

CEO says "focus remains on bringing an outstanding game to the market and letting the results speak"

Remedy reported revenue declines in the first half and second quarter of 2026 while increasing marketing efforts for Control Resonant.

CEO Jean-Charles Gaudechon said these results were expected and expressed confidence in Resonant's early reception before its September 24 launch.

Remedy attributed its Q2 and H1 revenue declines to the prior launch of FBC: Firebreak during the comparison period and increased marketing for Resonant.

Pre-orders for Resonant "opened with healthy momentum" and ranked among the top three pre-ordered PlayStation games in the US, Germany, and Brazil.

"Our data indicates the game is tracking well against comparable titles in its launch window," said Gaudechon. "In a competitive autumn window, we believe the distinctiveness and quality of the game will make it stand out.

"Combined with the release window becoming slightly less crowded since our original reveal, we remain confident in our positioning."

Revenue from game sales and royalties totaled €3.8 million, down from €9.5 million in the same period last year, which included contributions from Firebreak and initial subscription service accruals.

Sales of 2019's Control increased in Q2, supported by ongoing marketing for Control Resonant.

Alan Wake 2 exceeded three million lifetime sales, and royalties from both this title and Alan Wake Remastered were generated solely from consumer sales, with no platform deal accruals.

4 million in the previous period.



Source link
Related Topics:Gaming

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.